2016

The OIG’s recent Advisory Opinion suggest that under certain circumstances patient co-pay reimbursement programs are allowable.…

California Governor Jerry Brown recently signed legislation allowing terminally ill patients in his state to have access to…

According to the Ethics & Compliance Initiative (ECI), ethics and compliance programs should not be “check the box programs”…

Olympus Corp. has had its fair share of legal troubles, some of which culminated in a settlement of $646 million in early 2016.…

The Department of Health and Human Services has issued an Interim Final Rule, adjusting for inflation the maximum civil monetary…

The first year of CMS' voluntary Bundled Payments for Care Improvement initiative has yielded a mixed bag of results, according to…

Life sciences companies continue to be the target of whistleblower actions, not only on the federal level but the state level as…

In August, the FDA noted its concerns that citizen petitions do not raise valid scientific issues and are used to delay the…

On Wednesday, September 28, 2016, the House Ways and Means Oversight Subcommittee held a hearing on Health Care Fraud…

There has been much hubbub around the Yates Memorandum and what it means for compliance officers, especially in the life sciences…